Evidence map›Paper›PMID 35288741›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2022

Plasma Growth Factor Gene Expression and Mammographic Breast Density in Postmenopausal Women.

Favour A Akinjiyan, Andrea Adams, Shuai Xu, Mei Wang, Adetunji T Toriola

Open access · greenAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Favour A AkinjiyanMedical Scientist Training Program, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0003-0914-5567
Andrea AdamsDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri.
Shuai XuDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0002-7798-5720
Mei WangDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri.
Adetunji T ToriolaDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri.ORCID 0000-0003-1079-2606
Washington University in St. Louis · US

Funding

Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer PreventionR37CA235602 · NCI · WASHINGTON UNIVERSITY · PI TORIOLA, ADETUNJI T · 2019 to 2025
$4.2M
Metabolite Profiles and Mammographic Density in Premenopausal WomenR01CA246592 · NCI · WASHINGTON UNIVERSITY · PI TORIOLA, ADETUNJI T · 2020 to 2024
$1.8M
RANK PATHWAY AND MAMMOGRAPHIC DENSITY IN MID-LIFE WOMENR21CA216515 · NCI · WASHINGTON UNIVERSITY · PI TORIOLA, ADETUNJI T · 2017 to 2018
$376k
NCI NIH HHS R01 CA246592NCI NIH HHS R21 CA216515NCI NIH HHS R37 CA235602
6 · The paper itself

Abstract

Mammographic breast density (MBD) is a risk factor for breast cancer, but its molecular basis is poorly understood. Growth factors stimulate cellular and epithelial proliferation and could influence MBD via these mechanisms. Studies investigating the associations of circulating growth factors with MBD have, however, yielded conflicting results especially in postmenopausal women. We, therefore, investigated the associations of plasma growth factor gene expression [insulin-like growth factor (IGF)-1, IGF-binding protein 3, FGF-1, FGF-12, TGFβ1 and bone morphogenetic protein (BMP)-2] with MBD in postmenopausal women. We used NanoString nCounter platform to quantify plasma growth factor gene expression and Volpara to evaluate volumetric MBD measures. We investigated the associations of growth factor gene expression with MBD using both multiple linear regression (fold change) and multinomial logistic regression models, adjusted for potential confounders. The mean age of the 368 women enrolled was 58 years (range, 50-64). In analyses using linear regression models, one unit increase in IGF-1 gene expression was associated with a 35% higher volumetric percent density (VPD, 1.35; 95% confidence interval (CI), 1.13-1.60; P = 0.001). There were suggestions that TGFβ1 gene expression was positively associated with VPD while BMP-2 gene expression was inversely associated with VPD, but these were not statistically significant. In analyses using multinomial logistic regression, TGFβ1 gene expression was 33% higher (OR = 1.33; 95% CI, 1.13-1.56; P = 0.0008) in women with extremely dense breasts than those with almost entirely fatty breasts. There were no associations between growth factor gene expression and dense volume or nondense volume. Our study provides insights into the associations of growth factors with MBD in postmenopausal women and requires confirmation in other study populations. PREVENTION RELEVANCE: Mammographic breast density is a strong risk factor for breast cancer. Understanding its underlying biological mechanisms could have utility in breast cancer prevention.

Indexed as

Breast DensityBreast NeoplasmsFemaleGene ExpressionHumansMammographyMiddle AgedPostmenopause

Identifiers

PMID35288741
PMCPMC9167743
OpenAlexW4220749227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.